DNA copy number changes and immunophenotype pattern in karyotypically normal acute myeloid leukemia patients from an

Nikesh Kawankar1, Seema Korgaonkar, Lily Kerketta

  • 1Department of Cytogenetics, National Institute of Immunohaematology (NIIH), Parel, Mumbai, India. vbaburao@hotmail.com

Insights

This study found hidden DNA copy number variations in normal karyotype acute myeloid leukemia (AML) patients. These genetic changes correlate with aberrant immunophenotypes and impact disease prognosis.

Area of Science:

  • Hematology
  • Genetics
  • Oncology

Background:

  • Chromosomal abnormalities are critical for acute myeloid leukemia (AML) diagnosis and prognosis.
  • Karyotypically normal AML presents a diagnostic challenge, as standard cytogenetics may miss crucial genetic alterations.

Purpose of the Study:

  • To identify DNA copy number variations (CNVs) in karyotypically normal AML patients.
  • To investigate the correlation between these CNVs and patient immunophenotypes.

Main Methods:

  • Comparative genomic hybridization (CGH) was used to detect CNVs.
  • Immunophenotyping was performed on 46 untreated AML patients.
  • Patients with abnormal karyotypes were excluded, focusing on those with normal cytogenetics.

Main Results:

  • Out of 46 karyotypically normal AML patients, 24 (52.2%) exhibited DNA copy number variations (CNVs).
  • CNVs included both gains and losses across various chromosomes.
  • Aberrant immunophenotypes were observed in 13 of the 24 patients with CNVs (54%).

Conclusions:

  • CGH identified "hidden" chromosomal rearrangements missed by conventional cytogenetics and FISH in normal karyotype AML.
  • Detected genetic changes are significant for disease prognosis.
  • CNVs may contribute to aberrant immunophenotypes in this AML subgroup.